Seres Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2014 | $8.0M | $117.3M | $114.2M |
| FY2015 | $11.5M | $216.9M | $73.9M |
| FY2016 | $140.0M | $272.6M | $54.5M |
| FY2017 | $128.8M | $189.5M | $36.1M |
| FY2018 | $168.5M | $120.5M | $85.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2014 | $8.0M | $117.3M | $114.2M |
| FY2015 | $11.5M | $216.9M | $73.9M |
| FY2016 | $140.0M | $272.6M | $54.5M |
| FY2017 | $128.8M | $189.5M | $36.1M |
| FY2018 | $168.5M | $120.5M | $85.8M |